Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer’s COVID-19 vaccine under FDA’s examination following new research into adverse side effects

January 13, 2023
Medical Communications

The FDA, along with Taiwanese medical institutions, have been evaluating Pfizer’s mRNA COVID-19 vaccine, questioning the CDC’s omission of known …

News

Diabeloop and EOFlow team up to develop an automated insulin device

January 13, 2023
Medical Communications

Diabeloop, a medical device company focused on automated diabetes treatment solutions, and South Korea-based EOFlow have joined forces to offer …

News

First patient enrolled in Inari DEFIANCE trial for deep vein thrombosis

January 13, 2023
Research and Development

Inari Medical has announced that the first patient has been enrolled in the DEFIANCE trial. This trial will evaluate the …

News

MediciNova completes enrolment for phase 2 clinical trial of ibudilast to treat recurrent and newly diagnosed glioblastoma

January 13, 2023
Research and Development

Biopharmaceutical company MediciNova has announced that its phase 2 clinical trial to assess MN-166 (ibudilast) for the treatment of recurring …

News

Ajinomoto and Exelixis sign agreement to develop novel ADCs for cancer treatment

January 12, 2023
Research and Development

Ajinomoto Co., a Japanese biotech company providing biopharmaceuticals, has signed a license agreement with Exelixis Inc., an oncology-focused biotech company, …

News

BD showcase new-generation robotic track system for microbiology labs

January 12, 2023
Medical Communications

US-based Becton, Dickinson and Company (BD) has revealed new-generation robotic track system for its BD Kiestra microbiology laboratory solution which …

News

Oramed shares disappointing top-line results from phase 3 trial for type 2 diabetes treatment

January 12, 2023
Research and Development

Clinical stage pharmaceutical company, Oramed Pharmaceuticals, has announced top-line results from its phase 3 randomised, double-blind, placebo-controlled, multicentre trial, which …

News

Alvotech’s golimumab biosimilar phase 1 trial begins

January 12, 2023
Research and Development

Alvotech has announced that it has begun a phase 1 study evaluating the safety, tolerability and pharmacokinetics of its golimumab …

News

Avillion announces US approval of AstraZeneca’s Airsupra (PT027) as new rescue treatment for asthma

January 11, 2023
Business Services

London, UK, 11 January 2023 – Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical …

News
Press release

Ovarian Cancer Commitment launches digital patient support resource for anyone affected by ovarian cancer

January 11, 2023
Business Services

28 October 2022, 10:00 BST

News
Press release

New technology to “unlock” NHS records to revolutionise how we take medicine

January 11, 2023
Business Services

London, UK – New technology which can “unlock” medication records has been awarded £1m in fresh funding by Innovate UK.

News
Press release

FDA clears first ACL reconstruction device for use in paediatric patients

January 11, 2023
Medical Communications

The FDA has cleared the ACL TightRope® II implant to treat torn knee ligaments in children and adolescents. The implant …

News

AbbVie and Anima collaborate for mRNA biology modulators

January 11, 2023
Research and Development

AbbVie and Amina Biotech have announced their collaboration for the discovery and development of mRNA biology modulators focusing on three …

News

FDA grants approval to third-generation VERO Biotech GENOSYL delivery system

January 11, 2023
Research and Development

The FDA has approved US-based medical equipment supplier VERO Biotech’s new-generation tankless inhaled nitric oxide (iNO) delivery system. This new …

News

BioNTech acquires AI company InstaDeep for £562m

January 11, 2023
Medical Communications

Germany-based BioNTech has acquired UK AI start up InstaDeep for £562m after a multi-year partnership. The acquisition is part of …

News

Insilico Medicine shares positive topline results of phase 1 trial of AI-designed drug for AI-discovered target

January 10, 2023
Medical Communications

Clinical stage AI-driven drug R&D company, Insilico Medicine, has announced positive topline results from its phase 1 trial assessing the …

News

FDA issues Emergency Use Authorisation for BD and CerTest Biotec’s Monkeypox PCR test

January 10, 2023
Medical Communications

US medical technology company BD and Spanish biotechnology company CerTest Biotec have joined forces to develop a real-time Monkeypox test …

News

Day One Biopharmaceuticals to file NDA for paediatric brain cancer treatment before second half of 2023

January 10, 2023
Research and Development

Day One Biopharmaceuticals is set to ask the FDA for approval for tovorafenib before the summer of 2023. Tovorafenib is …

News

NHS to offer artificial pancreas to type 1 diabetes patients

January 10, 2023
Medical Communications

The NHS will soon be offering an artificial pancreas to more than 100,000 people with type 1 diabetes across England …

News

STORM Therapeutics Expands R&D Leadership Team

January 10, 2023
Business Services

10 January 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025